Junshi Biosciences Updates Board Composition and Committee Structure

Bulletin Express06-05

Shanghai Junshi Biosciences Co., Ltd. released an updated roster of its board of directors and committee assignments, effective 5 June 2026.

The 14-member Board now comprises: • Executive Directors (7): Mr. Xiong Jun (Chairman and Legal Representative), Dr. Li Ning (Vice Chairman), Dr. Zou Jianjun (Chief Executive Officer and General Manager), Mr. Li Cong (Co-Chief Executive Officer), Mr. Zhang Zhuobing, Dr. Wang Gang and Dr. Li Xin. • Non-executive Directors (2): Dr. Yao Sheng and Mr. Tang Yi. • Independent Non-executive Directors (5): Mr. Zhang Chun, Dr. Feng Xiaoyuan, Mr. Li Zhongxian, Ms. Lu Kun and Dr. Yang Jin.

Committee leadership and memberships are as follows: • Audit Committee – Chair: Mr. Zhang Chun; Members: Mr. Tang Yi, Mr. Li Zhongxian. • Nomination Committee – Chair: Dr. Feng Xiaoyuan; Members: Ms. Lu Kun. • Remuneration and Appraisal Committee – Chair: Mr. Zhang Chun; Members: Dr. Feng Xiaoyuan, Dr. Yang Jin. • Strategic and ESG Committee – Chair: Dr. Zou Jianjun; Members: Dr. Wang Gang, Mr. Zhang Chun, Dr. Feng Xiaoyuan. • Compliance Committee – Chair: Ms. Lu Kun; Members: Mr. Zhang Chun, Mr. Li Zhongxian.

The disclosure formalises current governance responsibilities, underscoring the Company’s multi-layered oversight structure that blends executive insight with independent supervision across audit, nomination, remuneration, strategy/ESG and compliance functions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166036115?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 22:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166036115","market":"us","top_or_hot":-1,"title":"Junshi Biosciences Updates Board Composition and Committee Structure","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. released an updated roster of its board of directors and committee assignments, effective 5 June 2026.</p>\n<p>The 14-member Board now comprises:  \n• Executive Directors (7): Mr. Xiong Jun (Chairman and Legal Representative), Dr. Li Ning (Vice Chairman), Dr. Zou Jianjun (Chief Executive Officer and General Manager), Mr. Li Cong (Co-Chief Executive Officer), Mr. Zhang Zhuobing, Dr. Wang Gang and Dr. Li Xin.  \n• Non-executive Directors (2): Dr. Yao Sheng and Mr. Tang Yi.  \n• Independent Non-executive Directors (5): Mr. Zhang Chun, Dr. Feng Xiaoyuan, Mr. Li Zhongxian, Ms. Lu Kun and Dr. Yang Jin.</p>\n<p>Committee leadership and memberships are as follows:  \n• Audit Committee – Chair: Mr. Zhang Chun; Members: Mr. Tang Yi, Mr. Li Zhongxian.  \n• Nomination Committee – Chair: Dr. Feng Xiaoyuan; Members: Ms. Lu Kun.  \n• Remuneration and Appraisal Committee – Chair: Mr. Zhang Chun; Members: Dr. Feng Xiaoyuan, Dr. Yang Jin.  \n• Strategic and ESG Committee – Chair: Dr. Zou Jianjun; Members: Dr. Wang Gang, Mr. Zhang Chun, Dr. Feng Xiaoyuan.  \n• Compliance Committee – Chair: Ms. Lu Kun; Members: Mr. Zhang Chun, Mr. Li Zhongxian.</p>\n<p>The disclosure formalises current governance responsibilities, underscoring the Company’s multi-layered oversight structure that blends executive insight with independent supervision across audit, nomination, remuneration, strategy/ESG and compliance functions.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Biosciences Updates Board Composition and Committee Structure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Biosciences Updates Board Composition and Committee Structure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-05 22:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. released an updated roster of its board of directors and committee assignments, effective 5 June 2026.</p>\n<p>The 14-member Board now comprises:  \n• Executive Directors (7): Mr. Xiong Jun (Chairman and Legal Representative), Dr. Li Ning (Vice Chairman), Dr. Zou Jianjun (Chief Executive Officer and General Manager), Mr. Li Cong (Co-Chief Executive Officer), Mr. Zhang Zhuobing, Dr. Wang Gang and Dr. Li Xin.  \n• Non-executive Directors (2): Dr. Yao Sheng and Mr. Tang Yi.  \n• Independent Non-executive Directors (5): Mr. Zhang Chun, Dr. Feng Xiaoyuan, Mr. Li Zhongxian, Ms. Lu Kun and Dr. Yang Jin.</p>\n<p>Committee leadership and memberships are as follows:  \n• Audit Committee – Chair: Mr. Zhang Chun; Members: Mr. Tang Yi, Mr. Li Zhongxian.  \n• Nomination Committee – Chair: Dr. Feng Xiaoyuan; Members: Ms. Lu Kun.  \n• Remuneration and Appraisal Committee – Chair: Mr. Zhang Chun; Members: Dr. Feng Xiaoyuan, Dr. Yang Jin.  \n• Strategic and ESG Committee – Chair: Dr. Zou Jianjun; Members: Dr. Wang Gang, Mr. Zhang Chun, Dr. Feng Xiaoyuan.  \n• Compliance Committee – Chair: Ms. Lu Kun; Members: Mr. Zhang Chun, Mr. Li Zhongxian.</p>\n<p>The disclosure formalises current governance responsibilities, underscoring the Company’s multi-layered oversight structure that blends executive insight with independent supervision across audit, nomination, remuneration, strategy/ESG and compliance functions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1166036115","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166036115","pubTimestamp":1780668176,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. released an updated roster of its board of directors and committee assignments, effective 5 June 2026. The 14-member Board now comprises:   • Executive Directors...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物更新董事会组成及委员会架构","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. released an updated roster of its board of directors and committee assignments, effective 5 June 2026.\nThe 14-member Board now comprises:  \n• Executive Directors (7): Mr. Xiong Jun (Chairman and Legal Representative), Dr. Li Ning (Vice Chairman), Dr. Zou Jianjun (Chief Executive Officer and General Manager), Mr. Li Cong (Co-Chief Executive Officer), Mr. Zhang Zhuobing, Dr. Wang Gang and Dr. Li Xin.  \n• Non-executive Directors (2): Dr. Yao Sheng and Mr. Tang Yi.  \n• Independent Non-executive Directors (5): Mr. Zhang Chun, Dr. Feng Xiaoyuan, Mr. Li Zhongxian, Ms. Lu Kun and Dr. Yang Jin.\nCommittee leadership and memberships are as follows:  \n• Audit Committee – Chair: Mr. Zhang Chun; Members: Mr. Tang Yi, Mr. Li Zhongxian.  \n• Nomination Committee – Chair: Dr. Feng Xiaoyuan; Members: Ms. Lu Kun.  \n• Remuneration and Appraisal Committee – Chair: Mr. Zhang Chun; Members: Dr. Feng Xiaoyuan, Dr. Yang Jin.  \n• Strategic and ESG Committee – Chair: Dr. Zou Jianjun; Members: Dr. Wang Gang, Mr. Zhang Chun, Dr. Feng Xiaoyuan.  \n• Compliance Committee – Chair: Ms. Lu Kun; Members: Mr. Zhang Chun, Mr. Li Zhongxian.\nThe disclosure formalises current governance responsibilities, underscoring the Company’s multi-layered oversight structure that blends executive insight with independent supervision across audit, nomination, remuneration, strategy/ESG and compliance functions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166036115","isCrawlerRequest":true}